NEW YORK (GenomeWeb News) – Precision BioSciences today said that the US Patent and Trademark Office is reexamining two patents that have been licensed to Cellectis and that are part of ongoing litigation between the two firms.

The patents — US Nos. 7,214,536 and 6,833,252 — are owned by the Institut Pasteur and the Universite Pierre et Marie Curie and have been licensed to Cellectis. They are among 13 issued US patents that Cellectis is asserting against Precision BioSciences.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.